Activity of novel benzoxazinorifamycins against rifamycin-resistant Streptococcus pyogenes [1]

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 5, 2006, Pages 1908-1909

  Mullin, Steve ^a   Rothstein, David M ^b   Murphy, Christopher K ^b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b ActivBiotics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOXAZINONE DERIVATIVE; RIFALAZIL; RIFAMYCIN; RIFAMYCIN DERIVATIVE; RNA POLYMERASE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BASE PAIRING; DRUG POTENCY; GENE IDENTIFICATION; GENE MUTATION; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; RIFAMYCINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 33646464974     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.5.1908-1909.2006     Document Type: Letter

References (13)

1. Achour, W., O. Guenni, M. Fines, R. Leclercq, and A. Ben Hassen. 2004. rpoB mutations in Streptococcus mitis clinical isolates resistant to rifampin. Antimicrob. Agents Chemother. 48:2757-2759.
2. Acocella, G. 1983. Pharmacokinetics and metabolism of rifampin in humans. Rev. Infect. Dis. 5(Suppl. 3):S428-S432.
3. Aubry-Damon, H., C. J. Soussy, and P. Courvalin. 1998. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 42:2590-2594.
4. Aubry-Damon, H., M. Galimand, G. Gerbaud, and P. Courvalin. 2002. rpoB mutation conferring rifampin resistance in Streptococcus pyogenes. Antimicrob. Agents Chemother. 46:1571-1573.
5. Chen, J. Y., C. P. Fung, F. Y. Chang, L. Y. Huang, J. C. Chang, and L. K. Siu. 2004. Mutations of the rpoB gene in rifampicin-resistant Streptococcus pneumoniae in Taiwan. J. Antimicrob. Chemother. 53:375-378.
6. Ferrandiz, M. J., C. Ardanuy, J. Linares, J. M. Garcia-Arenzana, E. Cercenado, A. Fleites, A. G. de la Campa, and the Spanish Pneumococcal Infection Study Network. 2005. New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals. Antimicrob. Agents Chemother. 49:2237-2245.
7. Herrera, L., C. Salcedo, B. Orden, B. Herranz, R. Martinez, A. Efstratiou, and J. A. Saez Nieto. 2002. Rifampin resistance in Streptococcus pyogenes. Eur. J. Clin. Microbiol. Infect. Dis. 21:411-413.
8. Jacobs, M. R., H. J. Koornhof, R. M. Robins-Browne, C. M. Stevenson, Z. A. Vermaak, I. Freiman, G. B. Miller, M. A. Witcomb, M. Isaacson, J. I. Ward, and R. Austrian. 1978. Emergence of multiply resistant pneumococci. N. Engl. J. Med. 299:735-740.
9. Meier, P. S., S. Utz, S. Aebi, and K. Muhlemann. 2003. Low-level resistance to rifampin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:863-868.
10. Murphy, C. K., S. Mullin, M. S. Osburne, J. van Duzer, J. Siedlecki, X. Yu, K. Kerstein, M. Cynamon, and D. M. Rothstein. 2006. In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 50:827-834.
11. NCCLS. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A6, vol. 23. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Padayachee, T., and K. P. Klugman. 1999. Molecular basis of rifampin resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:2361-2365.
13. Widmer, A. F., R. Frei, Z. Rajacic, and W. Zimmerli. 1990. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J. Infect. Dis. 162:96-102.